REFERENCES
- Huber W, Ilgmann K, Page M, . Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: Controlled, randomized, double-blinded study. Radiology. 2002;223:772–779.
- Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC, Jr. Radiocontrast medium-induced declines in renal function: A role for oxygen free radicals. Am J Physiol. 1990;258:115–120.
- Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: Evaluation of oxidant stress and plasma membrane integrity. Kidney Int. 2003;64:128–139.
- Heyman SN, Rosen S, Khamaisi M, Idee JM, Rosenberger C. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol. 2010;45:188–195.
- Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis. 1997;29:465–477.
- Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol. 2000;11:177–182.
- Noguchi N, Yoshida Y, Kaneda H, Yamamoto Y, Niki E. Action of ebselen as an antioxidant against lipid peroxidation. Biochem Pharmacol. 1992;44:39–44.
- Schewe T. Molecular actions of ebselen – An antiinflammatory antioxidant. Gen Pharmacol. 1995;26:1153–1169.
- Sies H, Masumoto H. Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite. Adv Pharmacol. 1997;38:229–246.
- Noiri E, Nakao A, Uchida K, . Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol. 2001;281:948–957.
- Yoshida M, Iizuka K, Terada A, . Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats. Tohoku J Exp Med. 2000;191:209–220.
- Baldew GS, McVie JG, van der Valk MA, Los G, de Goeij JJ, Vermeulen NP. Selective reduction of cis-diamminedichloroplatinum(ii) nephrotoxicity by ebselen. Cancer Res. 1990;50: 7031–7036.
- Yenicerioglu Y, Yilmaz O, Sarioglu S, . Effects of n-acetylcysteine on radiocontrast nephropathy in rats. Scand J Urol Nephrol. 2006;40:63–69.
- Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407–421.
- Aebi H. Catalase. New York: Academic Press; 1974:673–677.
- Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–169.
- Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497–500.
- Jost G, Pietsch H, Sommer J, . Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats. Invest Radiol. 2009;44:114–123.
- Andersen KJ, Christensen EI, Vik H. Effects of iodinated X-ray contrast media on renal epithelial cells in culture. Invest Radiol. 1994;29:955–962.
- Love L, Lind JA, Jr., Olson MC. Persistent ct nephrogram: Significance in the diagnosis of contrast nephropathy. Radiology. 1989;172:125–129.
- Clanton TL. Hypoxia-induced reactive oxygen species formation in skeletal muscle. J Appl Physiol. 2007;102:2379–2388.
- Shanley PF, Johnson GC. Oxygen metabolites and hypoxic renal injury: Effect of mitochondrial electron transport blockade. Ren Fail. 2002;24:249–258.
- Kolyada AY, Liangos O, Madias NE, Jaber BL. Protective effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury. Am J Nephrol. 2008;28:203–209.
- Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180–184.
- Merten GJ, Burgess WP, Gray LV, . Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA. 2004;291:2328–2334.
- Billings FT, Chen SW, Kim M, . Alpha2-adrenergic agonists protect against radiocontrast-induced nephropathy in mice. Am J Physiol Renal Physiol. 2008;295:741–748.
- Barlak A, Akar H, Yenicerioglu Y, Yenisey C, Meteoglu I, Yilmaz O. Effect of sodium bicarbonate in an experimental model of radiocontrast nephropathy. Ren Fail. 2010;32: 992–999.
- Lieberthal W, Nigam SK. Acute renal failure. Experimental models of acute renal failure: Imperfect but indispensable. Am J Physiol Renal Physiol. 2000;278:1–12.
- Vari RC, Natarajan LA, Whitescarver SA, Jackson BA, Ott CE. Induction, prevention and mechanisms of contrast media-induced acute renal failure. Kidney Int. 1988;33:699–707.
- Ma X, Zhang BR, Li DT. Value of urinary kidney injury molecule-1 protein in early diagnosis of radiocontrast-induced nephropathy in rats. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31:357–360.
- Yesildag A, Ozden A, Yilmaz HR, . Erdosteine modulates radiocontrast-induced hepatotoxicity in rat. Cell Biochem Funct. 2009;27:142–147.
- Dhanarajan R, Abraham P, Isaac B. Protective effect of ebselen, a selenoorganic drug, against gentamicin-induced renal damage in rats. Basic Clin Pharmacol Toxicol. 2006;99:267–272.
- Hamacher J, Stammberger U, Weber E, Lucas R, Wendel A. Ebselen improves ischemia-reperfusion injury after rat lung transplantation. Lung. 2009;187:98–103.
- Tunc T, Uysal B, Atabek C, . Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury. J Surg Res. 2009;155:210–216.
- Pawlas N, Nierwinska K, Stolecka A, Gabryel B, Pudelko A, Malecki A. Effects of n-acetylcysteine and ebselen on arachidonic acid release from astrocytes and neurons cultured in normoxic or simulated ischemic conditions. Pharmacol Rep. 2009;61:941–946.
- Husain K, Morris C, Whitworth C, Trammell GL, Rybak LP, Somani SM. Protection by ebselen against cisplatin-induced nephrotoxicity: Antioxidant system. Mol Cell Biochem. 1998;178:127–133.
- Kizilgun M, Poyrazoglu Y, Oztas Y, . Beneficial effects of n-acetylcysteine and ebselen on renal ischemia/reperfusion injury. Ren Fail. 2011;33:512–517.